| 6713645 |
Substituted tricyclics |
Susan E. Draheim, Robert D. Dillard, Edward David Mihelich, Jason Scott Sawyer, Douglas Wade Beight +17 more |
2004-03-30 |
$108,187,000 |
| 6509476 |
Process for preparing N-benzyl indoles |
Stephen R. Baker, Jeremy Gilmore, Russell Andrew Lewthwaite, Alexander McKillop, Jason Scott Sawyer +2 more |
2003-01-21 |
$165,930,000 |
| 6451839 |
Indole sPLA2 inhibitors |
Robert D. Dillard, Susan E. Draheim, Edward David Mihelich, Tulio Suarez |
2002-09-17 |
$209,972,000 |
| 6448284 |
Substituted tricyclics |
Daniel Jon Sall |
2002-09-10 |
$109,326,000 |
| 6433001 |
1H-indole-3-glyoxylamide sPLA2 inhibitors |
Robert D. Dillard, Susan E. Draheim |
2002-08-13 |
$98,121,000 |
| 6391908 |
Oxime amide indole type sPLA2 inhibitors |
Richard Waltz Harper, Michael Dean Kinnick, Ho-Shen Lin, John Michael Morin, Jr., Michael Enrico Richett |
2002-05-21 |
$135,593,000 |
| 6350774 |
Antithrombotic agents |
Jolie Ann Bastian, Nickolay Y Chirgadze, Michael Lyle Denney, Robert J. Foglesong, Richard Waltz Harper +9 more |
2002-02-26 |
$168,169,000 |
| 6252084 |
1H-indole-3-acetamide sPLA2 inhibitors |
Robert D. Dillard, Susan E. Draheim, Robert Hermann, Richard W. Schevitz |
2001-06-26 |
$203,013,000 |
| 6177440 |
Substituted tricyclics |
Susan E. Draheim, Robert D. Dillard, Edward David Mihelich, Jason Scott Sawyer, Douglas Wade Beight +17 more |
2001-01-23 |
$624,202,000 |
| 6175021 |
1H-indole-3-glyoxylamide sPLA2 inhibitors |
Robert D. Dillard, Susan E. Draheim |
2001-01-16 |
$243,198,000 |
| 6160120 |
Process for preparing n-benzyl indoles |
Stephen R. Baker, Jeremy Gilmore, Russell Andrew Lewthwaite, Alexander McKillop, Jason Scott Sawyer +2 more |
2000-12-12 |
$198,211,000 |
| 5919774 |
Pyrroles as sPLA.sub.2 inhibitors |
Robert D. Dillard, Susan E. Draheim |
1999-07-06 |
$61,549,000 |
| 5919810 |
1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors |
Robert D. Dillard, Susan E. Draheim |
1999-07-06 |
$61,549,000 |
| 5919943 |
Process for preparing 1H-indole-3-glyoxylamides |
Robert D. Dillard, Susan E. Draheim |
1999-07-06 |
$61,549,000 |
| 5807866 |
Process for preparing N-benzyl indoles |
Stephen R. Baker, Jeremy Gilmore, Russell Andrew Lewthwaite, Alexander McKillop, Jason Scott Sawyer +2 more |
1998-09-15 |
$121,140,000 |
| 5733923 |
1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors |
Robert D. Dillard, Susan E. Draheim |
1998-03-31 |
$86,352,000 |
| 5684034 |
1H-indole-3-acetamide sPLA.sub.2 inhibitors |
Robert D. Dillard, Susan E. Draheim, Robert Hermann, Richard W. Schevitz |
1997-11-04 |
$237,638,000 |
| 5654326 |
1H-indole-3-glyoxylamide SPLA.sub.2 inhibitors |
Robert D. Dillard, Susan E. Draheim |
1997-08-05 |
$93,697,000 |
| 5641800 |
1H-indole-1-functional sPLA.sub.2 inhibitors |
Robert D. Dillard, Susan E. Draheim |
1997-06-24 |
$61,514,000 |
| 5578634 |
1H-indole-3-acetic acid hydrazide sPLA.sub.2 inhibitors |
Robert D. Dillard, Susan E. Draheim, Robert Hermann, Richard W. Schevitz |
1996-11-26 |
$31,094,000 |
| 4801712 |
2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity |
Bennett C. Laguzza, Cynthia L. Nichols |
1989-01-31 |
$7,333,000 |
| 4683313 |
2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles |
Bennett C. Laguzza, Cynthia L. Nichols |
1987-07-28 |
$6,296,000 |
| 4500545 |
Hydroxyaminotetralincarboxamides |
Edmund C. Kornfeld, Robert D. Titus |
1985-02-19 |
$4,594,000 |
| 4448990 |
Hydroxyaminotetralincarboxamides |
Edmund C. Kornfeld, Robert D. Titus |
1984-05-15 |
$9,051,000 |
| 4367231 |
Method of using octahydro pyrazolo[3,4-g]quinolines |
Edmund C. Kornfeld |
1983-01-04 |
$26,683,000 |
